» Articles » PMID: 32201680

Advancing Preventive Interventions for Pregnant Women Who Are Opioid Using Via the Integration of Addiction and Mental Health Research

Overview
Journal Curr Addict Rep
Date 2020 Mar 24
PMID 32201680
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: This review examines how research focused on treatment for opioid use in perinatal populations and preventive interventions for postpartum psychopathology have remained separate, despite significant overlap.

Recent Findings: Guidelines for best practice in caring for pregnant women with opioid use disorder suggest the use of medication-assisted treatment with additional comprehensive care, including behavioral and mental health interventions. However, intervention research often mutually excludes these two populations, with studies of behavioral interventions for opioid use excluding women with psychopathology and research on preventive interventions for postpartum psychopathology excluding women who are substance using.

Summary: There is a limited evidence-base to inform the selection of appropriate preventive interventions for pregnant women with opioid use disorder that can address opioid use and/or treatment adherence and concurrent mental health risks. We argue it is critical to integrate research on pregnant women who are opioid using and preventive perinatal mental health interventions to catalyze pivotal change in how we address the opioid epidemic within this growing population.

Citing Articles

Substance use during pregnancy: the role of mindfulness in reducing stigma.

Shank T, Tjahaja S, Rutter T, Mackiewicz Seghete K Front Psychol. 2024; 15:1432926.

PMID: 38984277 PMC: 11231397. DOI: 10.3389/fpsyg.2024.1432926.


Opportunities to expand postpartum support for those in recovery from opioid use disorder: Results from a qualitative study.

Allen A, Bueno Y, Mallahan S, MacPherson A, Armin J Drug Alcohol Depend Rep. 2023; 7:100170.

PMID: 37334156 PMC: 10276205. DOI: 10.1016/j.dadr.2023.100170.


The association between preconception cannabis use and depression and anxiety during pregnancy.

Leng Q, Lo J, Rakshe S, Hildebrand A, Doyle O, Seghete K Gen Hosp Psychiatry. 2023; 83:148-155.

PMID: 37196406 PMC: 10428863. DOI: 10.1016/j.genhosppsych.2023.05.006.


Stakeholder Perspectives on Advancing Understanding of Prenatal Opioid Exposure and Brain Development From the iOPEN Consortium of the Healthy Brain and Child Development Study.

DiPietro J, Mackiewicz Seghete K, Krans E, Snider K, Bower R, Parker K Front Psychol. 2021; 12:698766.

PMID: 34393931 PMC: 8361604. DOI: 10.3389/fpsyg.2021.698766.

References
1.
Haight S, Ko J, Tong V, Bohm M, Callaghan W . Opioid Use Disorder Documented at Delivery Hospitalization - United States, 1999-2014. MMWR Morb Mortal Wkly Rep. 2018; 67(31):845-849. PMC: 6089335. DOI: 10.15585/mmwr.mm6731a1. View

2.
Swain J, Kim P, Spicer J, Ho S, Dayton C, Elmadih A . Approaching the biology of human parental attachment: brain imaging, oxytocin and coordinated assessments of mothers and fathers. Brain Res. 2014; 1580:78-101. PMC: 4157077. DOI: 10.1016/j.brainres.2014.03.007. View

3.
Musser E, Kaiser-Laurent H, Ablow J . The neural correlates of maternal sensitivity: an fMRI study. Dev Cogn Neurosci. 2012; 2(4):428-36. PMC: 7005764. DOI: 10.1016/j.dcn.2012.04.003. View

4.
OConnor E, Senger C, Henninger M, Coppola E, Gaynes B . Interventions to Prevent Perinatal Depression: Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2019; 321(6):588-601. DOI: 10.1001/jama.2018.20865. View

5.
Cioffi C, Leve L, Seeley J . Accelerating the Pace of Science: Improving Parenting Practices in Parents with Opioid Use Disorder. Parent Sci Pract. 2019; 19(3):244-266. PMC: 6771283. DOI: 10.1080/15295192.2019.1615801. View